Article Details
Retrieved on: 2022-04-22 21:17:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Tecentriq, developed by Roche unit Genentech, got a marketing authorization valid throughout the EU on Sept. 21, 2017.
Article found on: seekingalpha.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here